I almost feel like you two are agreeing with one another. Davisite says it's not right to take one statistical point that seems to champion the efficacy of BIT 225 and Southoz says it's legal to do this but don't take the accuracy of the result to the bank.
- Forums
- ASX - By Stock
- BIT
- Statistical issues in the analysis of BITs P2 trial
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

Statistical issues in the analysis of BITs P2 trial, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $306 | 153.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
56 | 38556027 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 18612843 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
56 | 38556027 | 0.002 |
31 | 75641001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 18612843 | 22 |
0.004 | 12820969 | 17 |
0.005 | 6690600 | 5 |
0.006 | 1200000 | 2 |
0.007 | 484188 | 1 |
Last trade - 14.30pm 04/07/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online